MGMT and glioblastoma: Our data showed that metformin could suppress MGMT expression in TMZ-resistant glioblastoma cells (LN229 (+IRL) TMZ-R), suggesting that it can be repurposed to overcome TMZ resistance in glioblastoma tissue.